Gene and Cell Therapy Educational Series Part 8: Pharmacy Leader Considerations for Cell and Gene Therapy

ACPE Activity Number: 0204-0000-26-038-H04-P
Release Date: January 21, 2026
Expiration Date: January 21, 2029
Activity Type: Knowledge-based
CE Credits: 0.75 contact hour
Activity Fee: Member – Free / Non-Member – Not Available

Activity Overview

Gene and cell therapies are quickly integrating into pharmacy practice and present unique challenges not encountered with traditional medications in the clinical pharmacy setting. Health-system pharmacies must take an active role in onboarding these therapies including evaluating biosafety precautions along the medication use pathway, assisting with the development of infrastructure to administer and monitor these therapies, and identifying the practical and financial implications of these therapies within the health-system.   

Accreditation

Target Audience

Learning Objectives

After participating in this CPE activity, participants should be able to:

Identify pharmacy supply chain needs and structures to ensure safe and efficient storage and handling of gene and cell therapies.
Recall financial options and impacts of gene and cell therapies on the health-system enterprise to make informed recommendations.
Describe key clinical operations requirements for pharmacies and the health-system to support gene and cell therapy care.

Schedule of Activities

Faculty

Relevant Financial Relationship Disclosure

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Methods and CE Requirements

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.

Online Program

Member

Free

Non-Member

N/A